Business Description
Reckitt Benckiser Group PLC
NAICS : 325611
103-105 Bath Road, Slough, Berkshire, GBR, SL1 3UH
Compare
Compare
Traded in other countries / regions
3RB.Germany
•
RB.Mexico
•
RB.Switzerland
•
RKT.UK
•
RBGLY.USA
Description
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | 2.37 | |||||
| Interest Coverage | 12.92 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.95 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.4 | |||||
| 3-Year EBITDA Growth Rate | -49 | |||||
| 3-Year FCF Growth Rate | -16 | |||||
| 3-Year Book Growth Rate | -20.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 3.62 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.48 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.5 | |||||
| 9-Day RSI | 45.55 | |||||
| 14-Day RSI | 50.96 | |||||
| 6-1 Month Momentum % | 8.62 | |||||
| 12-1 Month Momentum % | 13.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 101.76 | |||||
| Days Sales Outstanding | 49.66 | |||||
| Days Payable | 290.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.68 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 1.3 | |||||
| Forward Dividend Yield % | 2.68 | |||||
| 5-Year Yield-on-Cost % | 3.15 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.15 | |||||
| Operating Margin % | 22.73 | |||||
| Net Margin % | 22.47 | |||||
| ROE % | 39.86 | |||||
| ROA % | 10.9 | |||||
| ROIC % | 10.76 | |||||
| ROC (Joel Greenblatt) % | 164.43 | |||||
| ROCE % | 18.6 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.31 | |||||
| Forward PE Ratio | 19.19 | |||||
| PE Ratio without NRI | 15.32 | |||||
| Shiller PE Ratio | 25.7 | |||||
| PS Ratio | 3.44 | |||||
| PB Ratio | 5.22 | |||||
| Price-to-Free-Cash-Flow | 33.63 | |||||
| Price-to-Operating-Cash-Flow | 25.54 | |||||
| EV-to-EBIT | 15.23 | |||||
| EV-to-Forward-EBIT | 16.39 | |||||
| EV-to-EBITDA | 13.41 | |||||
| EV-to-Forward-EBITDA | 14.35 | |||||
| EV-to-Revenue | 4.07 | |||||
| EV-to-Forward-Revenue | 3.86 | |||||
| EV-to-FCF | 39.75 | |||||
| Price-to-Projected-FCF | 1.96 | |||||
| Price-to-Median-PS-Value | 0.94 | |||||
| Earnings Yield (Greenblatt) % | 6.57 | |||||
| Forward Rate of Return (Yacktman) % | -15.69 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 13,524 | ||
| EPS (TTM) (£) | 4.25 | ||
| Beta | 0.25 | ||
| Volatility % | 17.02 | ||
| 14-Day RSI | 50.96 | ||
| 14-Day ATR (£) | 1.349129 | ||
| 20-Day SMA (£) | 65.257 | ||
| 12-1 Month Momentum % | 13.83 | ||
| 52-Week Range (£) | 49.05163 - 68.24 | ||
| Shares Outstanding (Mil) | 715.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Reckitt Benckiser Group PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||